We are live on ! Find out more
COCH icon

Envoy Medical

20 hedge funds and large institutions have $2.74M invested in Envoy Medical in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

18% more funds holding

Funds holding: 17 → 20 (+3)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.07% less ownership

Funds ownership: 6% → 5.93% (-0.07%)

40% less capital invested

Capital invested by funds: $4.59M → $2.74M (-$1.85M)

Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
3
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

COCH Hedge Fund Activity: Q2 2024 in Review

20 of the 6,938 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q2 2024, worth a combined $2.74M — down 40% from $4.59M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new COCH positions and 5 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Corient Private Wealth, opening a new position worth an estimated $142K. The largest seller was Atlas Merchant Capital, cutting an estimated $163K.

  • 20 institutional investors held Envoy Medical (COCH) as of Q2 2024, up from 17 in Q1 2024.
  • Funds reported $2.74M of Envoy Medical stock for Q2 2024, down 40% quarter-over-quarter.
  • 8 funds opened new Envoy Medical positions in Q2 2024 and 5 closed out, a net change of +3 holders.
  • The largest Envoy Medical buyer in Q2 2024 was Corient Private Wealth, an estimated $142K added.
  • The largest Envoy Medical seller in Q2 2024 was Atlas Merchant Capital, an estimated $163K sold.

Based on aggregated 13F filings for Q2 2024.